Ubs Group Ag Aditxt, Inc. Transaction History

Ubs Group Ag

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$0.13 - $0.46 $3,925 - $13,889	30,195 New	30,195 $4,000
Q3 2021 Nov 15, 2021	SELL	$1.54 - $3.04 $5,165 - $10,196	-3,354 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$2.2 - $3.2 $7,378 - $10,732	3,354 New	3,354 $9,000
Q1 2021 May 12, 2021	SELL	$2.08 - $5.26 $26,079 - $65,949	-12,538 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$1.89 - $2.48 $23,696 - $31,094	12,538 New	12,538 $26,000

Ticker ADTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,161,130
Market Cap $1.37M
Description
Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immuno...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.